2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)
Descripción general
Resumen del artículo
These guidelines address cardiovascular care for cancer patients before, during, and after treatment, focusing on prevention, surveillance, and management of cancer therapy-related cardiovascular toxicity. They recommend baseline risk assessment, personalized surveillance protocols, and management strategies for various cancer therapies and cardiovascular conditions, emphasizing a multidisciplinary approach and patient involvement in care.
Explícamelo como si tuviera cinco años
Scientists found that cancer treatments can sometimes hurt your heart. So, doctors made new rules to help make sure your heart stays strong and healthy before, during, and after you get medicine for cancer.
Posibles conflictos de intereses
The task force received financial support from the ESC without industry involvement. Experts submitted declarations of interest, which were reviewed and published in a supplementary document available on the ESC website.
Limitaciones identificadas
Explicación de la calificación
This guideline provides valuable, comprehensive guidance for managing cardiovascular health in cancer patients, encompassing risk assessment, surveillance, prevention, and treatment of cardiovascular complications. It promotes a multidisciplinary approach and emphasizes personalized care, although further research and validation are needed in several areas.
Conviene saber
Este es el análisis de Starter. Paperzilla Pro verifica cada cita, investiga los antecedentes de los autores y las fuentes de financiación, y utiliza razonamiento avanzado con IA para ofrecer información más exhaustiva.
Explorar Pro →